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Summary
Wiskott-Aldrich syndrome (WAS) is a primary immu-
nodeficiency that manifests as increased susceptibil-
ity to many pathogens. Although the spectrum of
infections suffered by WAS patients is consistent
with defects in neutrophil (PMN) function, the conse-
quences of WAS protein (WASp) deficiency on this in-
nate immune cell have been unclear. We report that
deficiency of WASp in both human and murine PMNs
resulted in profound defects in clustering of b2 integ-
rins, leading to defective adhesion and transendothe-
lial migration under conditions of physiologic shear
flow. Wild-type PMNs redistributed clustered b2 integ-
rins to the uropod of the cell during active migration,
whereas WASp-deficient cells remain unpolarized.
The WASp-deficient PMNs also showed reduced in-
tegrin-dependent activation of degranulation and re-
spiratory burst. PMNs from a WAS patient manifested
similar defects in integrin clustering and signaling.
These results suggest that impaired b2 integrin func-
tion in WASp-deficient PMNs may contribute substan-
tially to the clinical immunodeficiency suffered by
WAS patients.
Introduction
The Wiskott-Aldrich syndrome (WAS) is an X-linked
primary immunodeficiency caused by genetic mutations
within the Wiskott-Aldrich protein (WASp). WAS patients
develop a variety of bacterial, viral, and fungal infections
(Burns et al., 2004a). WASp, which is exclusively ex-
pressed in hematopoietic cells, is important in regula-
ting actin cytoskeletal dynamics (Badour et al., 2004).
Its role in regulating blood cell shape, polarity, and mi-
gration underlies many of the clinical manifestations of
the disease. WASp-deficient mice are not as severely af-
fected as WAS patients, but many of the cellular defects
first observed in WAS patients have also been observed
in Was2/2 mice, thereby confirming that the knockout
animals are a good model of the disease (Snapper
et al., 1998; Zhang et al., 1999).
*Correspondence: clifford.lowell@ucsf.eduDespite the fact that most WAS patients suffer from
infections that are often associated with neutrophil
(PMN) dysfunction, the role of WASp in PMN biology
has been poorly studied. Early studies in WAS patients
revealed partial impairments in PMN chemotaxis; how-
ever, they were correctable with normal serum, implying
that the defect was not intrinsic to the PMN (see Burns
et al., 2004a). With more modern approaches of observ-
ing directed chemotaxis in Dunn chambers, PMNs from
WAS patients showed both normal directional and
speed of migration responses to classical chemoattrac-
tants such as formyl peptides and interleukin-8 (Zicha
et al., 1998). No obvious defects have been reported
in PMN adhesive function in either WAS patients or
Was2/2 mice. However, impaired phagocytosis of yeast
zymosan particles has been observed in Was2/2 murine
PMNs (Zhang et al., 1999).
In contrast, the contribution of PMN dysfunction to the
immunodeficiencies caused by leukocyte adhesion de-
ficiency (LAD) syndromes LAD I, LAD II, and LAD III is
well understood (Bunting et al., 2002). Each of these dis-
eases is characterized by impaired adhesion, migration,
and accumulation of PMNs at sites of infection, leading
to chronic infections. The pathophysiology of LAD I and
LAD III are directly attributable to b2 integrin dysfunction
in PMNs, either due to loss of integrin expression (LAD I)
or reduction in the ability to activate integrin affinity and
avidity changes via deficiency of RapI GTPase (LAD III).
It is reasonable to assume that impairment of PMN in-
tegrin function via loss of other signaling molecules,
such as WASp, could be a major contributor to immuno-
deficiency.
Defects in mononuclear cell adhesion and migration
have been reported in both WAS patients and Was2/2
mice. Mononuclear cells from WAS patients display
profound defects chemotactic responses, potentially
resulting from disruption of podosome formation (Ba-
dolato et al., 1998). Correlated with a lack of podo-
somes, WASp-deficient human dendritic cells (DCs)
fail to cluster their b2 integrins, and as a result these
cells have reduced adhesion to intracellular adhesion
molecule 1 (ICAM-1) under conditions of fluid shear
stress (Burns et al., 2004b). In Was2/2 mice, the inabil-
ity of DCs to form proper adhesion contacts leads to
impaired migratory responses from sites of antigen de-
position to regional lymph nodes (de Noronha et al.,
2005).
We have examined the role of WASp in PMN func-
tion by using both Was2/2 mice and cells from a
WAS patient. WASp-deficient murine PMNs displayed
a substantial defect in integrin clustering and redis-
tribution to the contact area during attachment to
ligand-coated surfaces (or endothelial monolayers),
leading to impaired adhesion and reduced integrin-
dependent activation. Similar results were observed
examining human PMNs from a WAS patient. The re-
duced capacity of WASp-deficient PMNs to form high-
avidity b2 integrin adhesive contacts may be a major
contributor to the immunodeficiency present in WAS
patients.
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286Figure 1. WASP-Deficient PMNs Fail to Cluster LFA-1 and Mac-1 during Adhesion under Static Conditions
(A) Wild-type andWas2/2PMNs were plated on glass coverslips coated with FCS or ICAM (10 min) or on monolayers of cultured TNF-a-activated
bEND.3 cells (20 min), in the absence of fluid shear stress, and then fixed and stained with anti-CD11a (LFA-1) or biotinoylated anti-CD11b
(Mac-1) followed by Alexa448-conjugated secondary Ab or Alexa594-conjugated streptavidin.
(B) Quantification of integrin clustering for either LFA-1 (left) or Mac-1 (right) in wt versus Was2/2 cells. Cells were plated on the indicated
surfaces, fixed and stained as shown in (A), and then clustered integrins were counted with Image J (NIH) analysis software. RGD, poly-RGD
peptide coated; Fibr, fibrinogen coated. Data shown are averaged from three separate experiments counting 100 cells per experiment. Error
bars are 6 SD. ***p < 0.001 between wt and Was2/2.Results
Clustering of LFA-1 and Mac-1 Is Impaired
inWas2/2 PMNs
In WASp-deficient dendritic cells, reduced clustering of
b2 integrins and poor podosome formation contributes
to the diminished adhesive and migratory capacity of
these cells (Burns et al., 2004b). Although neutrophils
(PMNs) do not form podosome-like structures, they do
cluster integrins during cell attachment. To address
whether WASp is involved in this process, we examined
integrin-clustering events in PMNs during static, i.e.,
nonshear flow, adhesion to extracellular matrix (ECM)-
coated surfaces in wild-type (wt) versus Was2/2 cells.
Clustering of CD11a (LFA-1) or CD11b (Mac-1) was de-
termined by immunofluorescence microscopy followed
by image analysis. Resting PMNs plated on ligand-
free surfaces displayed an even distribution of surface
LFA-1 or Mac-1 (Figure 1A), confirming flow cytometry
data (not shown) that showed equal expression of
these integrins by Was2/2 and wt cells. PMNs plated
on various ligand-coated surfaces (fibrinogen, ICAM-1,
poly-Arg-Gly-Asp [poly-RGD] peptide) or on tumor ne-
crosis factor (TNF-a)-activated murine brain endothelial
(bEND.3) cells under static conditions showed obvious
integrin clustering that accompanied cell spreading
(Figure 1A, with LFA-1 or Mac-1 cluster quantification
shown in Figure 1B). Although Was2/2 PMNs attached
to the various ligand-coated surfaces, the cells re-
mained predominately round and showed an 85%–95%reduction in integrin clustering (Figures 1A and 1B).
These data indicate that WASp-deficient PMNs fail to re-
organize their surface integrin molecules during attach-
ment to adhesive surfaces under standard static, non-
shear flow, conditions.
To obtain a more physiologically relevant view of in-
tegrin clustering during adhesion, we examined PMNs
under flow conditions by using alternating differential
interference contrast (DIC)—fluorescence video micros-
copy. Cells were stained with Alexa488-conjugated
Mac-1 or non-blocking LFA-1 mAbs, then perfused over
ICAM-1-coated coverslips a shear force of 0.3 dyne/
cm2. Under these conditions, the PMNs would attach
and then spread over the adhesive surface and sponta-
neously begin to migrate (Figure 2 and Movies S1–S8 in
the Supplemental Data available with this article online).
In wt cells, the transition from attachment to fully spread
and migrating cells occurred rapidly (usually less than 20
s). During this process, both LFA-1 and Mac-1 concen-
trated in the mid-hind region (uropod) of the migrating
wt cell, whereas the leading edge (lamellopodia) was
cleared of both integrins (Movies S2 and S4). Numerous
punctuate regions of clustered integrins can be seen in
the wt cells moving from the dense regions in the uropod
toward the midregion of the cell during directional
migration. In contrast, Was2/2 PMNs failed to redis-
tribute their LFA-1 or Mac-1 integrins to either side of
the cell during attachment to ICAM-1 (Figure 2, Movies
S6 and S8). Instead, in most of the Was2/2 cells, both
LFA-1 and Mac-1 tended to aggregate in the central
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287Figure 2. WASp-Deficient PMNs Have Impaired b2 Integrin Clustering during Adhesion under Shear Stress
Wild-type or Was2/2 PMNs were stained with anti-Mac-1-Alexa488 or nonblocking anti-LFA-1-Alexa488, and then passed over coverslips
coated with ICAM-1 at a shear stress of 0.3 dyne/cm2 at room temperature. Continuous video imaging was acquired with 2 s alteration between
DIC and fluorescence microscopy. Representative single-cell images were culled from various videos (at the indicated time frames) and overlaid.
The top eight rows of images show wt cells, stained with anti-LFA-1 (left four) or anti-Mac-1 (right four) adhering and migrating (direction indi-
cated by solid arrow). Lower panels show Was2/2 cells.region of the cell. Similar results were observed during
attachment to other adhesive surfaces (fibrinogen, poly-
RGD peptides, or bEND.3 cells; data not shown). Thus,
under both static adhesion conditions and in response
to physiologic shear force during perfusion over adhe-
sive surfaces, WASp-deficient PMNs failed to reorga-
nize their b2 integrins into clustered structures analo-
gous to those seen in wt cells.
Was2/2 PMNs Have Reduced Adhesion under
Shear Stress
A potential consequence of impaired integrin clustering
is reduced adhesive capacity of leukocytes. With stan-
dard binding assays done under static conditions, we
failed to see substantial differences in the ability of
Was2/2 PMNs to adhere to ICAM- or poly-RGD-coated
surfaces while delayed attachment was observed on fi-
brinogen (Figures S1A and S1B). As a more physiologic
assessment of PMN adhesion, we examined the ability
of wt versus WASp-deficient PMNs to roll, attach, and
firmly adhere to monolayers of murine L-cells stably ex-
pressing E-selectin and ICAM-1 (L-EI cells) at a venular
shear stress of 1 dyne/cm2. Under these conditions, ad-
hesion strengthening by integrin activation and mem-
brane clustering is critical for stable PMN-L-EI cell inter-
actions (Simon and Green, 2005). Under shear flow
conditions, the number of PMNs interacting (either roll-
ing or attached) with the L-EI monolayers was equivalent
between wt and Was2/2 cells (Figure 3A). Capture and
rolling of PMNs was mediated by E-selectin because in-
teractions were blocked by addition of E-selectin mAb
but were unaffected by anti-ICAM-1 or LFA-1. Similarly,
Was2/2 PMNs captured and rolled normally on periph-
eral node addressin (PNAd)-coated surfaces, indicating
that deficiency of WASp did not affect L-selectin-medi-
ated cell attachment. However, the number of interact-
ing Was2/2 PMNs that transitioned to firmly arrestedcells was reduced by 65% compared to wt PMNs, simi-
lar to effect seen with anti-ICAM or anti-LFA-1 treatment
of wt cells. PMN firm adhesion to L-EI cells in this assay
is dependent primarily on LFA-1, as Mac-1-deficient
cells adhered normally. Together these data demon-
strate that WASp-deficient PMNs are able to attach
and roll normally over an E-selectin-expressing cell
monolayer or over a PNAd-coated surface but that
LFA-1-ICAM-1-mediated PMN firm arrest was substan-
tially impaired.
In vivo chemokines and chemoattractants presented
on the apical surfaces of endothelial cells can promote
both adhesion and migration, depending on the density
of integrin ligands on the endothethium (Cinamon et al.,
2004). To determine whether the presence of an apically
presented chemoattractant, such as platelet-activating
factor (PAF), would mitigate the adhesive defect of
Was2/2 cells, we perfused PMNs over cellular mono-
layers pretreated with PAF. Addition of PAF did not af-
fect the ability of L-EI cells to support PMN adhesion
at 1 dyne/cm2, whereas it did facilitate improved wt leu-
kocyte adhesion to bEND.3 monolayers (Figure 3B). The
capacity of Was2/2 PMNs to adhere under shear flow
was not improved by addition of PAF.
We next examined the capacity of WASp-deficient
PMNs to form high-avidity adhesion clusters that could
resist progressively increasing amounts of shear stress.
For this experiment, PMNs were allowed to interact with
TNF-a-activated bEND.3 cells at low shear (0.3 dyne/
cm2), and then the percentage of cells that remained
firmly adherent at 1, 4, and 10 dyne/cm2 was deter-
mined. The percentage of wt cells that were able to re-
main adherent at 4 and 10 dyne/cm2 steps progressively
increased over the number at the 1 dyne/cm2 step,
whereas the few Was2/2 cells that arrested at 1 dyne/
cm2 were progressively washed away at the high shear
(Figure 3C). The increase in % adherent cells in the wt
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288Figure 3. Impaired Adhesion of Was2/2 PMNs under Shear Stress
(A) Wild-type, Was2/2, CD11b (Mac-1)-deficient, CD18-deficient, or L-selectin-deficient PMNs were injected into a parallel plate flow chamber
and passed over a monolayer of L-EI cells or PNAd-coated surfaces at a shear of 1 dyne/cm2 for 1 min. Video recordings were then taken at 30 s
intervals and the numbers of rolling or adherent cells were counted with Image Pro Plus v4.5 software. Interacting, rolling, or firmly adherent cells
are defined in Experimental Procedures. In some experiments, PMNs were pretreated with anti-E-selectin, anti-ICAM-1, or blocking anti-CD11a
(LFA-1) (10 mg/ml for 10 min) prior to injection into the flow cell.
(B) Wild-type and Was2/2 PMNs were passed over monolayers of L-EI- or TNF-a-activated murine bEND.3 cells, either with or without preincu-
bation with PAF (1 mM) for 5 min, at a shear of 1 dyne/cm2 for 1 min, and the number of firmly adherent cells was counted. For both (A) and (B), data
shown are mean 6 SD, n = 3–5 separate microscopy fields and are representative of at least three independent experiments.
(C) Wild-type or Was2/2 PMNs were allowed to interact with TNF-a-stimulated bEND.3 cell monolayer for 3 min at a shear force of 0.3 dyne/cm2,
after which the shear stress was ramped up to 1, 4, and 10 dyne/cm2 for 1 min each. The total number of arrested cells in a given microscopy field
were counted at each shear step, and the initial counts at the 1 dyne/cm2 level were indexed as 100%. Data shown are mean 6 SD, n = 3–5
separate microscopy fields.
(D) Wild-type, Was2/2, or CD18-deficient PMNswere mixed with fluorescent microbeads that had been precoated with ICAM-1-Fc at either low
density (20 mg/ml) or high density (70 mg/ml), then subjected to stirring at a rotary shear stress of 1 dyne/cm2. The rate of bead capture onto the
PMNs was determined by continuous flow cytometry from the stirring cells. After determination of bead binding in resting cells, the PMNs were
stimulated by addition of 3 mM fMLP to activate high-affinity integrin binding. Data shown are mean 6 SD, n = 3 and are representative of three
independent experiments. KO, knockout, e.g., CD11b KO is CD11b-deficient. *p < 0.05, **p < 0.01, ***p < 0.001 compared to wt.is due to rolling PMNs that entered the field of view dur-
ing the 1 or 4 dyne/cm2 step and then transitioned to
fully adherent cells capable of resisting higher shear.
Recruitment of Was2/2 cells at higher shear was nearly
absent. This indicates that the ability of Was2/2 PMNs
to strengthen adhesion contacts through LFA-1 cluster-
ing and formation of high-avidity interactions is consid-
erably reduced compared to wt cells.
To further assess the ability of Was2/2 PMNs to form
stable adhesion contacts, we used a flow cytometric-
based bead binding assay performed under rotational
shear of 1 dyne/cm2 (Lum et al., 2002). The rate of
ICAM-1 bead capture byWas2/2PMNs was significantly
reduced compared to wt cells, especially with beads
coated at a lower density of ICAM-1 (Figure 3D). Both
types of PMNs showed a dramatically increased rate
of bead binding after stimulation by fMLP, whereas
control CD18-deficient PMNs failed to bind beads at
all. These data confirm that, especially at low ICAM-1
site density, Was2/2 PMNs manifest decreased LFA-
1-mediated adhesion capacity under shear stress.Was2/2 PMNs Have Reduced Migratory Capacity
In Vitro and In Vivo
An obvious implication of the reduced adhesive capac-
ity of WASp-deficient PMNs should be reduced integrin-
dependent migratory ability. However, previous studies
had indicated that PMNs from WAS patients display nor-
mal speed and direction of motility in gradients of fMLP
or IL-8 within Dunn chemotaxis chambers (Zicha et al.,
1998). Indeed, in standard Transwell chamber type che-
motaxis assays, we found that murine Was2/2 PMNs
also migrated normally in response to MIP-1a, MIP-2,
or fMLP (Figure S1C). Under similar static conditions,
Was2/2 PMNs displayed no defect in their ability to
transmigrate through monolayers of murine bEND.3
cells in response to chemokine stimulation (Figure S1D).
However, given that the major defect in integrin-depen-
dent adhesion in Was2/2 PMNs was apparent only
under shear stress, we examined the ability of WASp-
deficient cells to transmigrate through a monolayer of
bEND.3 cells in parallel plate flow assays. Approxi-
mately 30% of the adherent wt cells accomplished
Integrin Functional Defects in WASp-Deficient PMNs
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ent Was2/2 or Mac-1-deficient cells transmigrated,
though duration from arrest to crossing the endothelium
was equivalent in both cell types (Figure 4A). Transmi-
gration was completely absent in CD18-deficient PMNs
or after blockade of wt cells with anti-LFA-1, as these
cells failed to adhere at all to the bEND.3 monolayer.
Pretreatment of the bEND.3 cells with PAF lowered
migration of both wt and Was2/2 cells, potentially due
to increased adhesion, but failed to rescue the relative
deficiency in the Was2/2 cells (Figure 4B). These obser-
vations demonstrate that under physiologic levels of
shear stress, Was2/2 PMNs manifest reduced adhesive
and migratory capacity.
To examine the ability of Was2/2 cells to migrate
in vivo, we used the thioglycollate peritonitis model. At
various time points after peritoneal installation of 3%
sterile thioglycollate, invading PMNs were enumerated
Figure 4. Was2/2 PMNs Display Reduced Transendothelial Migra-
tion In Vitro and In Vivo
(A) Wild-type, Was2/2, CD11b (Mac-1)-deficient or CD18-deficient
PMNs were injected into a parallel plate flow cell and passed over
a monolayer of TNF-a-activated murine bEND.3 cells at a shear of
0.3 dyne/cm2 for 1 min to promote adhesion, then ramped up to
1 dyne/cm2, after which cells observed for rolling, adhesion, and
transmigration. Transmigration was quantitated by counting the
phase dark PMNs that migrated beneath the endothelium and out
of the focal plane. The numbers of adherent cells that transmigrated
through the endothelial cell monolayer were counted over a total of
15 microscopy fields (total transmigrated cells counted w50–60 in
wt) and divided by the number of adherent cells in each field to
obtain the percentage transmigrating. In some experiments, anti-
CD11a was injected with the PMNs. Right panel shows the average
time for transmigration.
(B) Wild-type and Was2/2 PMNs were passed over monolayers of
L-EI- or TNF-a-activated murine bEND.3 cells, either with or without
preincubation with PAF (1 mM) for 5 min, at a shear of 0.3 dyne/cm2
for 1 min, and the percentage of firmly adherent cells that transmi-
grated through the monolayers was counted. For both (A) and (B),
data shown are mean6 SD, n = 3 PMN injections and representative
of at least two independent experiments.
(C) Wild-type or Was2/2 littermates mice were injected i.p. with 3%
thioglycollate, and the number of PMNs in peritoneal lavage fluid at
1, 2, 3, 6, 9, and 12 hr later was determined by flow cytometry (double
staining for CD45.2/Gr1). Data shown are based on 5 mice per group
and is representative of three independent experiments. Error bars
are 6 SD. **p < 0.01, ***p < 0.001 compared to wt.by Gr-1 and CD45 staining followed by flow cytometry.
WASp-deficient mice showed a clear delay in migration
of PMNs into the inflamed peritoneum compared to wt
littermate control animals (Figure 4C). At later time
points, as more macrophages enter the inflammatory
site, PMN numbers dropped in wt animals but remained
high inWas2/2mice, consistent with the known defect in
macrophage migration caused by WASp deficiency
(Jones et al., 2002).
Was2/2 PMNs Have Reduced Integrin-Dependent
Functional Responses
Of the two main b2 leukocyte integrins, LFA-1 plays
a greater role in leukocyte rolling, adhesion, and migra-
tion, whereas Mac-1 is more involved in leukocyte acti-
vation after adhesion (Ding et al., 1999). Because the in-
tegrin-clustering defect inWas2/2PMNs affected Mac-1
as much as LFA-1, we chose to examine leukocyte acti-
vation by adhesion as a better gauge of the functional
defects that may result from impaired Mac-1 (or b1/b3
integrin) signaling. Adhesion-mediated degranulation
of Was2/2 PMNs was reduced to near background (sim-
ilar to Mac-1-deficient cells) after plating on either col-
lagen- or fibrinogen-coated surfaces (Figure 5A). In
contrast, when these cells were stimulated with PMA,
which directly activates functional responses in the ab-
sence of adhesion, all cell types responded equivalently,
indicating that the Was mutation does not affect the
general machinery of degranulation.
Similar to degranulation, Was2/2 cells showed signif-
icantly reduced activation of respiratory burst after plat-
ing on serum-, fibrinogen-, poly-RGD-, or ICAM-1-
coated plates (Figure 5B). We were also able to detect
a much weaker respiratory burst when PMNs were
plated directly on TNF-a-stimulated bEND.3 cells; in
this assay, the Was2/2 cells were completely defective.
As a control, we also examined the degranulation and
respiratory burst responses of Was2/2 PMNs in sus-
pension (nonadhesive conditions) after activation with
a number of G protein-coupled receptor (GPCR) ago-
nists (fMLP, PAF, LTB4, and C5a). In all cases, adhe-
sion-independent activation of Was2/2 PMNs was nor-
mal (Figure S2), demonstrating that the mutation does
not intrinsically affect the function of the NADPH oxi-
dase or the major intracellular signaling pathways from
these GPCRs. However, as expected, GPCR-induced
activation of actin polymerization in suspended PMNs
was significantly reduced in theWas2/2 cells (Figure S3).
Reduced Adhesion and Activation of PMNs from
a Wiskott-Aldrich Syndrome Patient
To validate that the Was2/2 mice represent a good
model for PMN defects that may be present in human
WAS patients, we analyzed integrin clustering, adhesion
under shear flow, and integrin-mediated activation of
cells from a WAS donor. The patient has a point mutation
in the WAS gene (R86C), a common hotspot for substi-
tution mutations that are often associated with more se-
vere immunodeficiency (Kolluri et al., 1995). In this pa-
tient, the amount of WASp in PMNs was less than 10%
of normal (Figure 6A). Peripheral blood PMNs from this
patient showed a marked impairment in integrin cluster-
ing when plated on human ICAM-1-coated surfaces, re-
sembling the phenotype seen in murine Was2/2 cells
Immunity
290Figure 5. Was2/2 PMNs Display Impaired Integrin-Mediated Degranulation and Respiratory Burst Responses
(A) Wild-type, Was2/2, and CD11b (Mac-1)-deficient PMNs were plated in microtiter wells precoated with either collagen or fibrinogen, in the
presence or absence of TNF-a (10 ng/ml), then cultured for 90 min. Release of the secondary granule marker lactoferrin into the cell supernatant
was determined by ELISA. Data are mean 6 SD, n = 6 wells each and are representative of three independent experiments. In some samples,
PMA (1 nM) was added as a pharmacologic activator of PMN degranulation.
(B) Wild-type andWas2/2PMNs were plated on microtiter wells coated with the indicated ligands (RGD, polyRGD peptide) or containing a mono-
layer of TNF-a-treated bEND.3 cells, in cytochrome C media with and without TNF-a (10 ng/ml). Production of superoxides by respiratory burst
was measured as reduction of the cytochrome C. Data are mean, n = 3 wells each and are representative of at least three independent exper-
iments. Error bars are 6 SD. **p < 0.01, ***p < 0.001 compared to wt.(Figure 6B). In parallel plate shear flow assays, the PMNs
from this patient rolled normally on both TNF-a-stimu-
lated HUVEC and L-EI cells but demonstrated a clear de-
fect in arrest and firm adhesion (Figure 6C). The PMNs
from this patient also had an obvious defect in adhe-
sion-dependent activation of respiratory burst after
plating on human ICAM-1-, fibrinogen-, or poly-RGD
peptide-coated surfaces (Figure 6D). These data dem-
onstrate that in at least one individual, WASp deficiency
affects integrin function similarly in human and murine
PMNs.
Reduced Integrin-Dependent Signaling Events
inWas2/2 PMNs
Clustering of integrins after ligand binding initiates both
a Ca2+ flux and downstream phosphorylation of many
proteins, including tyrosine kinases such as Syk and
Pyk2, their substrates such as Vav and Cbl (which lead
to activation of the Erk1 and Erk2 pathway), and anti-
apoptotic pathways via Akt phosphorylation (Berton
et al., 2005). To determine whether the impaired integrin
clustering we observed in Was2/2 PMNs correlated withreduced integrin intracellular signaling, we examined
Ca2+ responses and tyrosine phosphorylation events in
wt versus Was2/2 PMNs. Plating on either fibrinogen-
or ICAM-1-coated surfaces produced an obvious and
transient Ca2+ response in wt but not Was2/2 PMNs
(Figure 7A). In contrast, Ca2+ flux responses induced
by fMLP stimulation of suspended cells were equivalent
in both wt and Was2/2 cells (data not shown).
Plating PMNs on poly-RGD-coated surfaces led to ac-
tivation of Erk1 and Erk2 in wt but not Was2/2 PMNs
(Figure 7B). In contrast, Erk1 and Erk2 activation oc-
curred normally in fMLP-stimulated Was2/2 cells in sus-
pension. Syk, Pyk2, Vav-1, and Cbl phosphorylation
were reduced in Was2/2 PMNs after adhesion to poly-
RGD-coated surfaces in the presence of TNF-a. As
seen in the Erk pathway, both fMLP- and integrin-medi-
ated adhesion can lead to formation of phospho-Akt;
however, only the integrin-mediated pathway was
affected in Was2/2 cells. Together, these data demon-
strate that most of the downstream pathways and func-
tional responses induced by chemoattractant signaling
(except induction of actin polymerization; Figure S3)
Integrin Functional Defects in WASp-Deficient PMNs
291Figure 6. PMNs from a Human WAS Patient Demonstrate Impaired Integrin Clustering, Reduced Adhesion under Shear Flow, and Poor Integrin-
Mediated Activation
(A) Peripheral blood PMNs (53 106) isolated from a healthy donor or a WAS patient (both >90% purity judged by flow cytometry) were lysed and
blotted with anti-human WASp. Filters were stripped and reprobed with anti-Erk1 and Erk2 to confirm equal loading.
(B) Peripheral blood PMNs from a healthy donor or the WAS patient were plated on FBS or human ICAM-1-coated coverslips, fixed, and then
stained as described for murine samples in Figure 1.
(C) Peripheral blood PMNs from healthy donors or the WAS patient were injected into a parallel plate flow chamber and passed over monolayers
of either TNF-a-treated HUVEC cells or L-EI cells at a shear of 1 dyne/cm2 for 1 min. Video recordings were then taken at 0.5 s intervals and the
numbers of adherent cells was counted as described in Figure 3. Data shown are mean6 SD, n = 3–5 separate microscopy fields and represen-
tative of three independent experiments.
(D) Normal donor or WAS patient PMNs were plated on microtiter wells coated with the indicated ligands, in the presence of TNF-a (10 ng/ml) and
superoxide production monitored as indicated in Figure 5. Data shown are mean, n = 3 wells each and are representative of three independent
experiments. Error bars are 6 SD. **p < 0.01, ***p < 0.001 compared to wt.were normal in Was2/2 cells; however, pathways down-
stream from leukocyte integrins after ligand engage-
ment and clustering were severely diminished.
To begin to address the basis for the impaired integrin
clustering and signaling defects in Was2/2 cells, we ex-
amined whether the altered cytoskeletal responses of
WASp-deficient PMNs resulted in impaired distribution
of integrins and key signaling molecules. Colocalization
of b2 integrins with phospho-Syk and phospho-Pyk2 in
the uropod regions of fully polarized cells was observed
in wt PMNs spreading on ICAM-1-coated surfaces but
not in Was2/2 PMNs (Figure S4A). In contrast, WASp
did not colocalize with either LFA-1 or Mac-1 in ICAM-
1 adherent neutrophils (Figure S4B). Additionally, phar-
macologic inhibition of PI3-kinase activity also blocked
Mac-1 and LFA-1 clustering, producing a phenotype
similar to Was2/2 cells or to treatment with cytochalasin
D (Figure S5). Overall, the correlation of impaired cyto-
skeletal responses, poor integrin signaling, and mis-localization of key signaling molecules at adhesion sites
with the impaired b2 integrin clustering in Was2/2 cells
suggests that a signaling loop between the integrins
and the cytoskeleton is impaired in WASp-deficient
cells.
The above results suggest that changes in the actin
cytoskeleton caused by WASp deficiency affect integrin
‘‘outside-in’’ signaling. To address whether altered cyto-
skeletal structures affect integrin affinity modulation
(‘‘inside-out’’ signaling), we performed staining of pe-
ripheral blood PMNs from our WAS patient with
mAb327C, a reporter of the high-affinity conformation
of human CD18 (Lupher et al., 2001). Over a dose range
of fMLP, we found no effect on integrin affinity modula-
tion in this patient’s PMNs as compared to a healthy
control donor (Figure S6). These data, together with
the observation that mouse PMNs can adhere to high-
density ICAM-1-coated beads, suggest that integrin
‘‘inside-out’’ signaling and a shift to high affinity is likely
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from WASp deficiency.
Discussion
In this study, we report that WASp-deficient murine
PMNs have defects in actin cytoskeletal function result-
ing in impaired clustering of b2 integrins after adhesion.
As a result, formation of LFA-1 clusters is reduced in
Was2/2 PMNs, which is correlated with reduced cell ar-
rest and transendothelial migration in shear flow. Poor
clustering of Mac-1 in the Was2/2 cells leads to reduced
outside-in signaling of effector functions including de-
granulation and respiratory burst. A similar phenotype
was observed in peripheral blood PMNs from a Wis-
kott-Aldrich Syndrome patient. The capacity for b2-
integrins to mediate attachment and chemotaxis was
not completely defective and only became manifest
under conditions of physiologic shear flow. In the ab-
sence of applied shear stress, the integrin redistribution
Figure 7. Reduced Integrin-Mediated Signaling in Was2/2 PMNs
(A) Wild-type and Was2/2 PMNs loaded with fluo-3 (2 3 106 cells in
100ml) were plated on fibrinogen- or ICAM-1-coated microtiter plates
at 37C, and fluorescence at 530 nm was monitored every 0.5 s. Data
shown are representative of four independent experiments.
(B) Wild-type and Was2/2 PMNs (1.53 107 cells in 2 ml) were plated
on RGD-coated tissue culture plates (in the presence or absence of
TNF-a at 50 ng/ml) for 30 min. Control samples were unplated and
some samples were stimulated with fMLP (3 mM) in suspension. After
stimulation, whole-cell lysates were prepared and immunoblotted
with phospho-specific anti-Erk1 and Erk2 or anti-Akt, then reprobed
with total Erk1-2 or Akt to confirm equivalent loading. Phosphoryla-
tion of Pyk 2, Cbl, Syk, and Vav-1 was determined by immunoprecip-
itation of each protein followed by blotting for phosphotyrosine.
Blots were reprobed with anti-Pyk2, Cbl, Syk, or Vav-1 to confirm
equal loading. Data shown are representative of three to five sepa-
rate experiments.defects associated with WASp deficiency were also
manifest, but the impaired adhesive outcome of these
defects is simply better reflected in shear flow assays.
This may explain why previous investigators have
reported normal chemotaxis of PMNs from WAS pa-
tients—because the experiments were done under
static conditions (Zicha et al., 1998). In vivo, these de-
fects in WASp-deficient PMN adhesion and activation
are likely to be quite substantial. Therefore, the relative
contribution of PMN dysfunction to the overall immuno-
deficiency in WAS patients may have been previously
underestimated.
The underlying cell biologic defect in Was2/2 PMNs,
macrophages, and DCs may be quite similar, despite
that fact that the phenotypes of these cells seem at first
glance to be different. The primary defect in WASp-defi-
cient macrophages and DCs is an inability to form podo-
somes, which are specialized areas of contact between
the cell and substratum that serve as points of enrich-
ment for cell adhesion molecules (Burns et al., 2004a).
As a result, WASp-deficient DCs fail to cluster their b2
integrins appropriately and display defects in adhesion
strengthening (Burns et al., 2004b). This reduced adhe-
sive capacity likely contributes to impaired chemotaxis
ofWas2/2macrophages and DCs, under standard static
conditions, as well as the reduced homing capacity of
WASp-deficient DCs in vivo (de Noronha et al., 2005).
However, PMNs do not form podosomes as a mecha-
nism for cell attachment or adhesion. Like mononuclear
cells, PMNs also depend on the ability to form clusters of
high-affinity integrins for normal adhesive function, and
when this is disrupted (for example, after pharmacologic
blockade of the shift to high-affinity sites) (Green et al.,
2006), defects in integrin-mediated activation result.
Unlike mononuclear cells, it appears that aggregation
of integrins may not be required for chemotactic re-
sponses of PMNs under static conditions. Thus, normal
chemotaxis responses are seen in PMNs from mice lack-
ing the major signaling molecules downstream from the
integrins, such as Src-family and Syk kinase-deficient
cells or Vav1-Vav3 double mutant cells (Gakidis et al.,
2004; Mocsai et al., 2002). In all cases, it has been pro-
posed that only minimal adhesive function (i.e., cell at-
tachment) is required for the PMN to be able to mount
a migratory response in standard Boyden chamber
type chemotaxis assay. The fact that macrophages and
DCs require more complex adhesive structures (i.e., po-
dosomes) to mount migratory responses in culture,
whereas PMNs apparently do not, may be the simple
explanation for the different chemotactic responses be-
tween Was2/2 macrophages/dendritic cells and PMNs.
The impairment in endothelial transmigration present
in Was2/2 cells is not surprising given the clear role for
b2 integrins in this process. A number of studies have
demonstrated that coordinate redistribution of endothe-
lial ICAM-1 and PMN b2 integrins into ring-like or cup-
like structures is required for efficient trans and paracel-
lular migration (Carman and Springer, 2004; Shaw et al.,
2004). Similarly, the presence of chemokines along the
apical surface of the endothelial cell as well as the den-
sity of b2 ligands (mainly ICAM-1) also influences the
rate and mode of transendothelial migration (Cinamon
et al., 2004). Given the obvious defect in b2 integrin clus-
tering in Was2/2 PMNs, it will be important to examine
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both autoimmune and infectious disease models.
In this report, we have concentrated on those signal-
ing response and functions that are downstream of in-
tegrin ligation. However, it is likely that the WASp is
also involved in integrating signals from other PMN re-
ceptors as well. In this regard, we can comment on the
role of WASp in GPCR signaling. As expected, stimula-
tion of Was2/2 PMNs with chemokines or chemoattrac-
tants (MIP-1a, MIP-2, or fMLP) failed to induce substan-
tial actin-polymerization responses. However, a number
of GPCR agonists induced normal chemotaxis, degran-
ulation, respiratory burst, and intracellular signaling
responses in suspended Was2/2 cells. Similarly, fMLP
stimulated increased binding to high-density coated
ICAM-1 beads and produced normal integrin affinity
modulation via reporter mAb staining in WASp-deficient
human PMNs. Hence, it appears that many of the pri-
mary signaling responses from GPCRs do not depend
on WASp function.
Our observations support the conclusion that WASp is
mainly involved in ‘‘oustide-in’’ integrin signaling path-
ways. At first glance, the impaired proximal integrin sig-
naling events (tyrosine kinase activation) in Was2/2 cells
may appear to be unexpected, since actin polymeriza-
tion responses requiring WASp should be downstream
from tyrosine phosphorylation. However, it may be
somewhat simplistic to view ‘‘outside-in’’ integrin signal-
ing as a sequential and linear pathway that is occurring
simultaneously from all receptors in the cell. It is more
likely that initial integrin engagement induces mem-
brane-localized kinase activation and actin polymeriza-
tion, which in turn activates signaling leading to more
integrin clustering and further integrin signaling—in the
fashion of a circular feed-forward loop pathway. Lack
of WASp blocks this signal amplification. Therefore,
while our observations appear to demonstrate a very
early proximal defect in the integrin-signaling pathway
(leading to poor activation and localization of tyrosine ki-
nases) as the underlying cause of the PMN dysfunction
in WASp-deficient cells, it is perhaps more accurate to
think of the pathway as failing to amplify a signaling loop.
Overall, these results demonstrate that like other cells
in the innate immune system, PMNs are highly depen-
dent on WASp for normal function. It will be an important
question for future work to determine how much of the
overall immune deficiency caused by lack of this protein
is due to PMN dysfunction. In mouse models, lineage-




CD18- and CD11b-deficient mice were purchased from Jackson
Laboratory. Was2/2 mice, originally made by Snapper et al. (1998),
were kindly provided by Dr. Arie Abo (PPD Pharmaceuticals, Foster
City, CA). Animals were kept in a specific pathogen-free facility at
UCSF and used according to protocols approved by the UCSF Com-
mittee on Animal Research. The original Was2/2 mice were back-
crossed to C57BL/6 background for four generations, and all exper-
iments were performed with the backcrossed animals.
Reagents and mAbs
Recombinant murine or human TNF-a (from Becton Dickinson),
fMLP, PAF, LTB4, and C5a (from Sigma) were used at 10–20 ng/ml,3 mM, 1 mM, 15 nM, and 50 ng/ml, respectively. Cytochalasin D
(from Sigma) was used at the indicated doses. Poly-RGD peptides
(Calbiochem), human plasma fibrinogen (ICN Biomedicals), and col-
lagen (Sigma) were used to coat plates as previously described (Per-
eira and Lowell, 2003). PNAd (MECA-79-reactive ligands, known as
the peripheral node addressins from human tonsil) was kindly pro-
vided by S. Rosen (UCSF). Anti-Mac-1 (CD11b, clone M1/70), anti-
LFA-1 (CD11a, clone M17/4), and non-blocking anti-LFA-1 (clone
2D7) were from Becton Dickinson/Pharmingen. Phospho-ERK1/2,
phospho-Akt, phospho-JNK, phospho-p38, phospho-Pyk2, and
phospho-Syk were purchased from Cell Signaling. Anti-WAS mono-
clonal antibody gelatin-free antibody (for labeling with Alexa647
according to Molecular Probes protocol), anti-ERK1/2, Cbl, Vav-1,
human WASp, and Pyk2 polyclonal Abs were purchased from Santa
Cruz Biotechnology.
PMN Isolation and Cell Lines
Murine bone marrow PMNs were isolated with a one-step 62% den-
sity gradient medium, as previously described (Pereira and Lowell,
2003). Human peripheral blood PMNs were isolated by dextran sed-
imentation of RBCs, followed by pelleting in Ficoll-Paque Plus
(Amersham). The murine bEND.3 cell line, a brain capillary endothe-
lial cell line immortalized by retroviral transduction with polyoma
middle T antigen, was kindly provided by Dr. Eric Brown (UCSF).
Transfected L-cells coexpressing E-selectin and ICAM-1 (L-EI) and
human umbilical vein endothelial cells (HUVECs) were maintained
as described (Green et al., 2004).
Fixed and Live Cell Immunofluorescence Microscopy
PMN integrin clustering was determined by plating cells (2.53105/ml
in 150 ml) on coverslips coated with the indicated proteins at 37C
for 10 min, followed by fixing in 2% paraformaldehyde for 10 min
(at 37C), then staining for CD11a or CD11b. PMN clustering induced
by binding to bEND.3 cells was determined by plating cells for 20 min
on coverslips on which a monolayer of bEND.3 cells had been acti-
vated by incubation with TNF-a for 4 hr prior to use. Integrin clusters
were counted with Image J (NIH) analysis software. Regions of dis-
continuous membrane integrin staining of at least 3-fold above back-
ground were defined as integrin clusters.
The topography of LFA-1 and Mac-1 was imaged in real time with
alternating DIC/fluorescence video microscopy during PMN arrest
in shear flow. PMNs were stained with Alexa488-conjugated anti-
Mac-1 (clone M1/70) or nonblocking anti-LFA-1 (clone 2D7) at
20 mg/ml at 4C for 30 min, then perfused over ICAM-1-coated
coverslips at a concentration of 2.5 3 106/ml with a shear force
of 0.3 dyne/cm2 while imaging was initiated. Image acquisition
was achieved with an inverted Axiovert 200 M microscope and
a 340/1.4 lens (Carl Zeiss, NJ), equipped with a 175 W xenon high-
speed DG4 wavelength selector and a single emission filter wheel
(Sutter Instruments, Novato, CA), a PI piezoelectric z-drive (Physik
Instrument, Germany), and a cooled-CCD Coolsnap camera (Roper
Instruments, NJ). Data were acquired and analyzed with Metamorph
(Universal Imaging, Downingtown, PA), and static cell images were
analyzed with Image J (NIH) analysis software. For live-cell imaging,
data were acquired every 2 s and consisted of single DIC image
followed by a 490/20 excitation and 528/38 emission to detect
Alexa488 staining. Images were collected over a 200 s period.
PMN Adhesion and Transendothelial Migration
under Shear Flow
PMN adhesion under flow conditions was measured in a parallel
plate flow chamber, as described previously (Green et al., 2004). Iso-
lated PMNs (106/ml) were passed over confluent L-EI monolayers at
1.0 dynes/cm2 for 1 min at 37C, after which digital image sequences
were acquired with a TE200 microscope (Nikon) equipped with
a 403 phase contrast objective and analog CCD camera. Image
sequences were captured and analyzed with Image Pro Plus v4.5
(Media Cybernetics). Rolling PMNs were defined as cells having
moved greater that one cell diameter in 30 s with velocity computed
as the distance rolled divided by the period of time a cell traversed
the field of view. Arrested PMNs were defined as those cells that
moved less than one cell diameter in 30 s. The fractions of rolling
and arrested cells were determined by normalizing to the total num-
ber of PMNs interacting with the L-EI or bEND.3 cell monolayer, both
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migration was determined by passing PMNs over L-EI or bEND.3
cell monolayers, stimulated with murine TNF-a (10 ng/ml) for 4 hr
prior. Transendothelial migration was assessed by counting the
number of fully arrested PMNs that migrated to the junction between
endothelial cells and then transitioned to phase darkness as they
migrated below the endothelial monolayer.
ICAM-1 Bead Binding Assay
Quantitative binding of ICAM-1-coated latex beads to murine PMNs
was performed as described (Lum et al., 2002; Tsang et al., 1997).
Fluorescent latex beads (1 mm diameter, Molecular Probes) were
coated with recombinant ICAM-1-Fc at 20 and 70 mg/ml. PMNs were
mixed with ICAM-1-coated beads in sample volumes of 200 ml
(HEPES buffer, 1.5 mM CaCl2) containing 10
6 PMNs with 2 3 107
beads in FACs test tubes with a small magnetic stirring bar. Samples
were run on the flow cytometer for 1 min to establish a baseline
reading, and then fMLP was added to 5 mM and cells were analyzed
continuously for 5 min while being stirred at a shear stress of
1.0 dyne/cm2. Binding of ICAM-1-coated beads was determined
by gating on PMNs with FSC/SSC, and the rate of bead capture
was determined as described (Lum et al., 2002; Tsang et al., 1997).
PMN Migration In Vivo
PMN migration in vivo was observed in the thioglycollate-induced
sterile peritonitis model as described (Gakidis et al., 2004; Mocsai
et al., 2002). Since a fraction of Was2/2 mice have chronic colitis
and hematocelia starting around 4 months of age (Snapper et al.,
1998; Zhang et al., 1999), we used 6-week-old mice for this experi-
ment. Any mice with evidence of hematocelia after thioglycollate
were not included in the data analysis.
PMN Functional Assays
Adhesion-dependent respiratory burst and degranulation assays
were performed essentially as described (Lowell et al., 1996; Mocsai
et al., 1999; Pereira and Lowell, 2003). Coating of 96-well tissue cul-
ture plates was done with fibrinogen (10 mg/ml), poly-RGD peptide
(20 mg/ml), ICAM-1 (0.5 mg/ml), or collagen (10 mg/ml). Monolayers
of bEND.3 cells were obtained by culturing cells in 96-well plates
until completely confluent. Adherent respiratory burst was mea-
sured by a cytochrome C reduction, while degranulation of the sec-
ondary granule marker lactoferrin was determined by ELISA from
cell supernatants.
Assays of Integrin Signaling
Adhesion-dependent calcium flux was determined by fluo-3 loading
cells as described (Zhang et al., 2005) followed by plating in micro-
titer wells precoated with fibrinogen or ICAM-1. Calcium flux was
measured by Mithras LB 940 plate reader with 480 excitation and
530 emission every 0.5 s for 15 min. Adhesion-dependent phosphor-
ylation of Erk1, Erk2, Pyk2, Syk, Cbl, Vav-1, or Akt was determined
as previously described (Zhang et al., 2005). PMNs (107 cells in
2 ml of HBSS with Ca2+/Mg2+) were allowed to adhere to poly-
RGD-coated 35 mm dishes for 30 min in either the presence or ab-
sence of TNF-a at 37C in a 5% CO2 incubator. Attached cells
were lysed by addition of RIPA buffer before immunoprecipitation
with antibody to Pyk2, Syk, Vav-1, or Cbl, separation by SDS-
PAGE, and detection of tyrosine phosphorylated proteins by West-
ern blotting with mAb 4G10 antibody. Immunoprecipitations were
controlled for equal loading by stripping the blotting membrane
and reprobing with the same Ab as used for precipitation. For detec-
tion of ERK1/2, p38, and JNK phosphorylation, PMN lysates were
separated by SDS-PAGE, followed by Western blotting with phos-
pho-specific ERK1/2, phospho-p38, and phospho-JNK antibodies.
Supplemental Data
Supplemental Data include six figures and eight movies and can be
found with this article online at http://www.immunity.com/cgi/
content/full/25/2/285/DC1/.
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